COronary Microcirculation and Troponin Elevation in Septic Shock
Key facts
- Who runs it
- Karolinska Institutet
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 62 people enrolled
- Started
- 13 Jun 2019
- Ended
- 28 Feb 2025
- Type of study
- Observational
- Record updated
- 29 June 2025
Who can take part
- Age
- 40 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (15)Hide the full registry criteria
Who can take part
- Patients fulfilling the Sepsis-3 definition of and diagnostic criteria for sepsis or septic shock
- Age 40 - 85 years
- Life expectancy > 1 year
- hs-cTnT values >15 ng/L
Who cannot take part
- previous medical history of coronary artery by-pass grafting
- a medical history of abdominal, thoracic, or orthopaedic surgery within the last three months prior to hospital admission
- heart transplant
- amyloidosis or sarcoidosis with myocardial engagement
- previously verified ejection fraction (EF) ≤39% prior to hospital admission
- estimated glomerular filtration rate (eGFR) <30 mL/min/1.73m2 prior to hospital admission
- pregnancy
- Hypertrophic cardiomyopathy (Septum > 15 mm)
- severe aortic stenosis
- asthma
- infectious endocarditis
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Plasma cardiac troponin (cTn) elevation is an indicator of increased mortality in patients with sepsis yet the underlying cause of troponin elevation in sepsis is not known. The COMTESS study investigates whether elevated high-sensitive cardiac Troponin T (hs-cTnT) levels in hemodynamically unstable patients with sepsis can be explained by an underlying coronary artery disease or a process within the coronary microcirculation. Fifty patients with sepsis and with hs-cTnT elevation (>15 ng/L) will undergo coronary angiography, including an assessment of coronary flow using a method called thermo-dilution to record the index of microcirculatory resistance (IMR) in the left anterior descending artery (LAD). The relationship between IMR and hs-cTnT will subsequently be analysed. It is important to identify the underlying causes of elevated cTn during sepsis to target further research with an aim to improve the survival in patients suffering from this condition.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Coronary Microcirculation and Troponin Elevation in Septic Shock
- Publications
- Coronary microvascular function in patients with sepsis and myocardial injury: an invasive coronary physiology study.Critical care (London, England), 2026
- Record updated
- 29 June 2025